The renal consequences of arterial hypertension

Kidney International

Volumn 51, Issue 5, 1997, Pages 1639-1653

  Mountokalakis, T D ^a  

^a SOTIRIA GENERAL HOSPITAL   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; BLOOD PRESSURE MONITORING; CASE REPORT; CORONARY RISK; HUMAN; HYPERTENSION; KIDNEY BLOOD FLOW; KIDNEY FAILURE; MALE; PRIORITY JOURNAL; RENIN RELEASE; REVIEW;

EID: 0030959504     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1038/ki.1997.226     Document Type: Article

References (109)

1. R. Bright Cases and observations illustrative of renal disease accompanied with secretion of albuminous urine Guy's Hosp Rep 1 1836 338 350
2. I.H. Page J.W. McCubbin Renal Hypertension 1968 Year Book Medical Chicago
3. P.J. Goldblatt A.F. Gohara N.H. Kahn J.A. Hampton Benign and malignant nephrosclerosis and renovascular hypertension C.C. Tischer B.M. Brenner Renal Pathology with Clinical and Functional Correlations 1989 Lippincott Philadelphia
4. G. Perera Hypertensive vascular disease: description and natural history J Chronic Dis 1 1955 33 42
5. Veterans Administration Cooperative Study Group on Antihypertensive Agents Effects of treatment on morbidity in hypertension. Results in patients with diastolic blood pressures averaging 115 through 129 mm Hg JAMA 202 1967 116 122
6. Veterans Administration Cooperative Study Group on Antihypertensive Agents II. Effects of treatment on morbidity in hypertension. Results in patients with diastolic blood pressures averaging 90 through 114 mm Hg JAMA 213 1970 1143 1152
7. P. Zucchelli A. Zuccala Primary hypertension—how does it cause renal failure Nephrol Dial Transplant 9 1994 223 225
8. P.K. Whelton M.J. Klag Hypertension as a risk factor for renal disease. Review of clinical and epidemiological evidence Hypertension 13 suppl 1 1989 I19 I27
9. United States Renal Data System USRDS 1990 Annual Data Report 1990 The National Institutes of Health, National Institute ofDiabetes and Digestive and Kidney Disease Bethesda, MD
10. European Dialysis and Transplant Association (EDTA), Registry Annual Report on Management of Renal Failure in Europe 1993 XXIV
11. F.P. Brunner N.H. Selwood Profile of patients on RRT in Europe and death rates due to major causes of death groups Kidney Int 42 suppl 38 1992 S4 S15
12. P.K. Whelton T.V. Perneger F.L. Brancati M.J. Klag Epidemiology and prevention of blood pressure-related renal disease J Hypertens 10 suppl 7 1992 S77 S84
13. L.M. Ruilope J.M. Alcazar J.L. Rodicio Renal consequences of arterial hypertension Hypertens 10 suppl 7 1992 S85 S90
14. J. Swales Renal dysfunction in essential hypertension Lancet 345 1995 740 741
15. P.C. Brazy W.W. Stead J.F. Fitzwilliam Progression of renal insufficiency: Role of blood pressure Kidney Int 35 1989 670 674
16. P.C. Brazy J.F. Fitzwilliam Progressive renal disease: Role of race and antihypertensive medications Kidney Int 37 1990 1113 1119
17. S.G. Rostand G. Brown K.A. Kirk E.A. Rutsky H.P. Dustan Renal insufficiency in treated essential hypertension N Engl J Med 320 1989 684 688
18. J.M. Weisstuch L.D. Dworkin Does essential hypertension cause end-stage renal disease Kidney Int 41 suppl 36 1992 S33 S37
19. S.J. Rosansky D.R. Hoover L. King J. Gibson The association of blood pressure levels and change in renal function in hypertensive and nonhypertensive subjects Arch Intern Med 150 1990 2073 2076
20. A. Innes P.A. Johnston A.G. Morgan A.M. Davison R.P. Burden Clinical features of benign hypertensive nephrosclerosis at time of renal biopsy Q J Med 86 1993 271 275
21. R.D. Lindeman J.D. Tobin N.W. Shock Association between blood pressure and the rate of decline in renal function with age Kidney Int 26 1984 861 868
22. T.V. Perneger J. Nieto P.C. Whelton M.J. Klag G.W. Comstock M. Szklo A prospective study of blood pressure and serum creatinine JAMA 269 1993 488 493
23. S. Madhavan D. Stockell H. Cohen M.H. Alderman Renal function during antihypertensive treatment Lancet 345 1995 749 751
24. N.B. Shulman C.E. Ford W.D. Hall M.C. Blaufox D. Simon H. Langford On behalf of the Hypertension Detection and Follow-up Program Cooperative Group: Prognostic value of serum creatinine and the effect of treatment of hypertension on renal function: results from the Hypertension Detection and Follow-up Program Hypertension 13 suppl 1 1989 180 193
25. G.W. Walker J.D. Neaton J.A. Cutler R. Neuwirth J.D. Cohen Renal function change in hypertension members of the Multiple Risk Factor Intervention Trial: racial and treatment effects JAMA 268 1992 3085 3091
26. P. De Leeuw W.H. Birkenhager The renal circulation in essential hypertension J Hypertens 1 1983 321 331
27. D.M. Shoback G.H. Williams T.D. Moore R.G. Dluhy S. Podolsky N.K. Hollenberg Defect in the sodium-modulated tissue responsiveness to angiotensin II in essential hypertension J Clin Invest 72 1983 2115 2124
28. I.M.S. Van Hooft D.E. Grobbee F.H.M. Derkx P. De Leeuw M.A.D.H. Schalekamp A. Hofman Renal hemodynamics and the renin-angiotensin-aldosterone system in normotensive subjects with hypertensive and normotensive parents N Engl J Med 324 1991 1305 1311
29. J. Ofstad G. Horvei F.I. Kvam L. Morkrid I. Sekse E. Svarstad B.M. Iversen Glomerular hemodynamics in progressive renal disease Kidney Int 41 suppl 36 1992 S8 S14
30. B.M. Iversen I. Sekse J. Ofstad Resetting of renal blood flow autoregulation in spontaneous hypertensive rats Am J Physiol 252 1987 F480 F486
31. L.C. Moore J. Schnermann S. Yarimizu Feedback mediation of SNGFR autoregulation in hydropenic and DOCA-salt loaded rats Am J Physiol 237 1 1979 F63 F74
32. G. Remuzzi T. Bertani Is glomerulosclerosis a consequence of altered glomerular permeability to macromolecules Kidney Int 38 1990 384 394
33. B.M. Brenner T.W. Meyer T.H. Hostetter Dietary protein intake and the progressive nature of kidney disease: The role of hemodynamically mediated glomerular injury in the pathogenesis of progressive glomerular sclerosis in aging, renal ablation, and intrinsic renal disease N Engl J Med 307 1982 652 659
34. F.C. Luft H. Haller Hypertension-induced renal injury: is mechanically mediated interstitial inflammation involved Nephrol Dial Transplant 10 1995 9 11
35. D.C. Wheeler Lipids—what is the evidence for their role in progressive renal disease Nephrol Dial Transplant 10 1995 14 16
36. A.M. El Nahas Renal scarring: the role of angiotensin II Nephrol Dial Transplant 10 suppl 9 1995 28 32
37. A.M. El Nahas Growth factors and glomerular sclerosis Kidney Int 41 suppl 36 1992 S15 S20
38. H.H. Parving H.A. Jensen C.E. Mogensen P.E. Evrin Increased urinary albumin excretion rate in benign essential hypertension Lancet 1 1974 1190 1194
39. 2-microglobulin hyperexcretion in recent severe essential hypertension J Hypertens 1 1983 45 51
40. A.A. Eddy Interstitial nephritis induced by protein-overload proteinuria Am J Pathol 135 1989 719 733
41. J.H. Moyer C. Heider K. Pevey R.V. Ford The effect of treatment on vascular deterioration associated with hypertension, with particular emphasis on renal function Am J Med 24 1958 177 182
42. J. Coope T.S. Warrender Randomised treatment of hypertension in elderly patients in primary care Br Med J 293 1986 1145 1151
43. P.W. De Leeuw on behalf of the European Working Party on High Blood Pressure in the Elderly: Renal function in the elderly: results from the European Working Party on High Blood Pressure in the Elderly trial Am J Med 90 suppl 3A 1991 45S 49S
44. P. Van Brummelen M. Woerlee M.A.D.H. Schalekamp Long-term versus short-term effect of hydrochlorothiazide on renal haemodynamics in essential hypertension Clin Sci 56 1979 463 469
45. X.H. Krauss M.A.D.H. Schalekamp G. Kolsters G.A. Zaal W.H. Birkenhager Effects of chronic beta-adrenergic blockade on systemic and renal haemodynamic responses to hypertonic saline in hypertensive patients Clin Sci 43 1972 385 391
46. L.M. Ruilope V. Lahera J.L. Rodicio J.C. Romero Are renal hemodynamics a key factor in the development and maintenance of arterial hypertension in humans Hypertension 23 1994 3 9
47. J.H. Bauer L.B. Jones P. Gaddy Effects of prazosin therapy on blood pressure, renal function, and body fluid composition Arch Intern Med 144 1984 1196 1200
48. N.K. Hollenberg L.G. Meggs G.H. Williams J. Katz J.D. Garnic D.P. Harrington Sodium intake and renal responses to captopril in normal man and in essential hypertension Kidney Int 20 1981 240 245
49. H.R. Brunner J. Nussberger Angiotensin converting enzyme inhibition and the normal kidney Kidney Int 31 suppl 20 1987 S104 S107
50. P.A. Kalra H. Mamtora A.M. Holmes S. Waldek Renovascular disease and renal complications of angiotensin-converting enzyme inhibitor therapy Q J Med 77 1990 1013 1018
51. S. Andersen H.G. Rennke B.M. Brenner The therapeutic advantage of converting enzyme inhibitors in arresting progressive renal disease associated with systemic hypertension in the rat J Clin Invest 77 1986 1993 2000
52. L.D. Dworkin H.D. Feiner J. Randazzo Glomerular hypertension and injury in desoxycorticosterone-salt rats on antihypertensive therapy Kidney Int 31 1987 718 724
53. L.D. Dworkin M. Grosser H.D. Feiner M. Ullian M. Parker Renal vascular effects of antihypertensive therapy in uninephrectomized SHR Kidney Int 35 1989 790 798
54. R. Zatz S. Anderson T.W. Meyer B.R. Dunn H. Rennke B.M. Brenner Lowering of arterial pressure limits glomerular sclerosis in rats with renal ablation and in experimental diabetes Kidney Int 31 suppl 20 1987 S123 S129
55. H.H. Parving U.M. Smidt A.R. Andersen P.A. Svendsen Early aggressive antihypertensive treatment reduces rate of decline in kidney function in diabetic nephropathy Lancet 1 1983 1175 1178
56. R. Anderson H.G. Rennke L.D. Garcia B.M. Brenner S.L. Riley D.J. Sandstrom Short and long term effects of antihypertensive therapy in the diabetic rat Kidney Int 36 1989 526 536
57. N. Perico S.C. Amuchastegui V. Colosio G. Sonzogni T. Bertani G. Remuzzi Evidence that an angiotensin-converting enzyme inhibitor has a different effect on glomerular injury according to the different phase of the disease at which the treatment is started J Am Soc Nephrol 5 1994 1139 1146
58. S. Bjorck G. Nyberg H. Mulec S. Granerus H. Herlitz M. Aurell Beneficial effects of angiotensin converting enzyme inhibition on renal function in patients with diabetic nephropathy Br Med J 293 1986 467 470
59. A. Mimran A. Insua J. Ribstein L. Monnier J. Bringer J. Mirouze Contrasting effects of captopril and nifedipine in normotensive patients with incipient diabetic nephropathy J Hypertens 6 1988 919 923
60. V.A. Valentino M.D. Wilson W. Weart G.L. Bakris A perspective on converting enzyme inhibitors and calcium channel antagonists in diabetic renal disease Arch Intern Med 151 1991 2367 2372
61. E.R. Mathiesen K. Hommel J. Giese H.H. Parving Efficacy of captopril in postponing nephropathy in normotensive insulin dependent diabetic patients with microalbuminuria Br Med J 303 1991 81 87
62. E.J. Lewis I.G. Hunsicker R.P. Bain R.D. Rohde The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy N Engl J Med 329 1993 1456 1462
63. B.L. Kasiske R.S.N. Kalil J.Z. Ma M. Lia W.F. Keane Effect of antihypertensive therapy on the kidney in patients with diabetes: a meta-regression analysis Ann Intern Med 118 1993 129 138
64. J.H. Bauer Are angiotensin-converting enzyme inhibitors the renal protective antihypertensive drug of choice Curr Opin Nephrol Hypertens 4 1995 427 431
65. R. Loutzenhiser M. Epstein The renal hemodynamic effects of calcium antagonists M. Epstein R. Loutzenhiser Calcium Antagonists and the Kidney 1990 Hanley & Belfus Philadelphia 33 73
66. M. Epstein Calcium antagonists and renal protection: current status and future perspectives Arch Intern Med 152 1992 1573 1584
67. P.M. Ter Wie A.G. De Micheli M. Epstein Effects of calcium antagonists on renal hemodynamics and progression of nondiabetic chronic renal disease Arch Intern Med 154 1994 1185 1202
68. S. Anderson H.G. Rennke B.M. Brenner Nifedipine versus fosinopril in uninephrectomized diabetic rats Kidney Int 41 1992 891 897
69. A. Mimran J. Ribstein Angiotensin-converting enzyme inhibitors versus calcium antagonists in the progression of renal diseases Am J Hypertens 7 1994 73S 81S
70. T. Baba S. Murabayashi K. Takebe Comparison of the renal effects of angiotensin converting enzyme inhibitor and calcium antagonist in hypertensive type 2 (non-insulin-dependent) diabetic patients with microalbuminuria: a randomised controlled trial Diabetologia 32 1989 40 44
71. G.L. Bakris B.W. Barnhill R. Sadler Treatment of arterial hypertension in diabetic humans: importance of therapeutic selection Kidney Int 41 1992 912 919
72. R. Slapater N. Vicknair R. Sadler G.L. Bakris Comparative effects of different antihypertensive treatments on progression of diabetic renal disease Arch Intern Med 153 1993 973 980
73. G.C. Viberti R.D. Hill R.J. Jarret A. Argyropoulos U. Mahmud H. Keen Microalbuminuria as a predictor of clinical nephropathy in insulin-dependent diabetes mellitus Lancet 1 1982 1430 1432
74. C.E. Mogensen Nephrology Forum: Microalbuminuria as a predictor of clinical diabetic nephropathy Kidney Int 31 1987 673 689
75. J.H. Bauer G.P. Reams J. Hewett D. Klachko A. Lau C. Messina V. Knauss A randomized, double-blind, placebo-controlled trial to evaluate the effect of enalapril in patients with clinical diabetic nephropathy Am J Kidney Dis 20 1992 443 457
76. P. Zucchelli A. Zuccala M. Borghi M. Fusaroli M. Sasdelli C. Stallone G. Sanna R. Gaggi Long-term comparison between captopril and nifedipine in the progression of renal insufficiency Kidney Int 42 1992 452 458
77. R.T. Gansevoort W.J. Sluiter M.H. Hemmelder D. De Zeeuw P.E. De Jong Antiproteinuric effect of blood-pressure-lowering agents: a meta-analysis of comparative trials Nephrol Dial Transplant 10 1995 1963 1974
78. D.D. Maki J.Z. Ma T.A. Louis B.L. Kasiske Long-term effects of antihypertensive agents on proteinuria and renal function Arch Intern Med 155 1995 1073 1080
79. S. Klahr The kidney in hypertensionvillain and victim N Engl J Med 320 1989 731 733
80. Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure The fifth report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure (JNC V) Arch Intern Med 153 1993 154 183
81. S. Klahr A.S. Levey G.J. Beck A.W. Caggiula L. Hunsicker J.W. Kusek G. Striker for the Modification of Diet in Renal Disease Study Group: The effects of dietary protein restriction and blood-pressure control on the progression on chronic renal disease N Engl J Med 330 1994 877 884
82. J.C. Peterson S. Adler J.M. Burkhart T. Greene L.A. Hebert L.G. Hunsicker A.J. King S. Klahr S. Massry J.L. Seifter for the Modification of Diet in Renal Disease (MDRD) Study Group: Blood pressure control, proteinuria, and the progression of renal disease Ann Intern Med 123 1995 754 762
83. R. Dussing W. Siffert Sodium-proton exchange and primary hypertension Hypertension 26 1995 649 655
84. R. Nosadini A. Semplicini P. Fioretto L. Lusiani R. Trevisan V. Donadon G. Zanette G.L. Nicolosi V. Dall'Aglio D. Zanuttini G. Viberti Sodium-lithium countertransport and cardiorenal abnormalities in essential hypertension Hypertension 18 1991 191 198
85. + antiport activity of cultured skin fibroblasts from diabetics Kidney Int 42 1990 1184 1190
86. W.H. Herman D.E. Prior M.D. Yassine A.B. Weder Nephropathy in NIDDM is associated with cellular markers for hypertension Diabetes Care 16 1993 815 818
87. R. Bigazzi S. Bianchi D. Baldari G. Sgherri G. Baldari V.M. Campese Microalbuminuria in salt-sensitive patients. A marker for renal and cardiovascular risk factors Hypertension 23 1994 195 199
88. B.I. Freedman S.S. Iskandar V.M. Buckalew J.M. Burkart R.G. Appel Renal biopsy findings in presumed nephrosclerosis Am J Nephrol 14 1994 90 94
89. H. Hsu J. Churg The ultrastructure of mucoid “onion skin” intimal lesions in malignant nephrosclerosis Am J Pathol 99 1980 67 80
90. T. Gilbert M. Lelievre-Pegorier C. Merlet-Benichou Glomerular damage in adult rats born with mild oligonephronia of protein-deprived mothers J Am Soc Nephrol 1 1990 629 (abstract)
91. C.M. Law M. De Swiet C. Osmond P.M. Fayers D.J.P. Barker A.M. Cruddas C.H.D. Fall Initiation of hypertension in utero and its amplification throughout life Br Med J 306 1993 24 27
92. G. Gennser P. Rymark P.E. Isberg Low birth weight and risk of high blood pressure in adulthood Br Med J 296 1988 1498 1500
93. C.M. Law D.J.P. Barker Fetal influences on blood pressure J Hypertens 12 1994 1329 1332
94. A. Lucas R. Morley Does early nutrition in infants born before term programme later blood pressure Br Med J 309 1994 304 308
95. SHEP Cooperative Research Group Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension JAMA 265 1991 3255 3264
96. B. Dahlof L.H. Lindholm L. Hansson B. Scherten T. Ekbom P.-O. Wester Morbidity and mortality in the Swedish Trial in Old Patients with Hypertension (STOP-Hypertension) Lancet 338 1991 1281 1285
97. MRC Working Party Medical Research Council trial on treatment of hypertension in older adults Br Med J 304 1992 405 412
98. D. Fouque M. Laville J.B. Boissel R. Chifflet M. Labeeuw P.Y. Zech Controlled low-protein diets in chronic renal insufficiency: meta-analysis Br Med J 304 1993 216 220
99. F. Locatelli D. Marcelli M. Comelli D. Alberti G. Graziani G. Buccianti B. Redaelli A. Giangrande the Northern Italian Cooperative Study Group Proteinuria and blood pressure as causal components of progression to end-stage renal failure Nephrol Dial Transplant 11 1996 461 467
100. F.H. Messerli E.D. Frohlich G.R. Dreslinski D.H. Suarez G.G. Aristimuno Serum uric acid in essential hypertension: an indicator of renal vascular involvement Ann Intern Med 93 1980 817 821
101. V.L. Burt P. Welton E.J. Rocella C. Brown J.A. Cutler M. Higgins M.J. Horan D. Labarthe Prevalence of hypertension in the US adult population. Results from the third National Health and Nutrition Examination Survey, 1988-1991 Hypertension 25 1995 305 313
102. P. Trenkwalder D. Ruland M. Stender J. Gebhard C. Trenkwalder H. Lydtin H.-W. Hense Prevalence, awareness, treatment and control of hypertension in a population over the age of 65 years: results from the Starnberg Study on Epidemiology of Parkinsonism and Hypertension in the Elderly (STEPHY) Hypertens 12 1994 709 716
103. S.B. Dimmitt S.M. Eames P. Gosling J.N.W. West J.M. Gibson W.A. Littler Usefulness of ophthalmoscopy in mild-to-moderate hypertension Lancet 1 1989 1103 1106
104. G.P. Reams J.H. Bauer Effect of lisinopril monotherapy on renal hemodynamics Am J Kidney Dis 11 1988 499 507
105. G. Maschio D. Alberti G. Janin F. Locatelli J.F.E. Mann M. Motolese C. Ponticelli E. Ritz P. Zucchelli The angiotensin-Converting-Enzyme Inhibition in Progressive Renal Insufficiency Study Group Effect of the angiotensin-enzyme inhibitor benazepril on the progression of chronic renal insufficiency N Engl J Med 334 1996 939 945
106. H. Yoshida T. Mitarai T. Kawamura T. Kitajima Y. Miyazaki R. Nagasawa Y. Kawaguchi H. Kubo I. Ichikawa O. Sakai Role of deletion polymorphism of the angiotensin converting enzyme gene in the progression and therapeutic responsiveness of IgA nephropathy Clin Invest 96 1995 2162 2169
107. G.G. Van Essen P.L. Rensma D. De Zeeuw W.J. Sluiter H. Scheffer A.J. Apperloo P.E. De Jong Association between angiotensin-converting-enzyme gene polymorphism and failure of renoprotective therapy Lancet 347 1966 94 95
108. S.H. Jacobson O. Eklof L.E. Lins I. Wikstad J. Winberg Long-term prognosis in post-infectious renal scarring in relation to radiologic findings in childhood: a 27-year follow-up Pediatr Nephrol 6 1992 19 24
109. J.L. Reid Drug treatment of hypertension Kidney Int 44 suppl 42 1993 S68 S70